SHREVEPORT, La. - Starget Pharma Inc, a U.S. clinical-stage radiopharmaceutical company, announced the closing of its $18M Series A financing round and a strategic collaboration with the Center for Mo ...

ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today announced a strategic investment from Catalio ...

Future Market Insights (FMI) reports that the global stem cell therapy market was valued at USD 18.7 billion in 2025 and is projected to ...

Tempest outlines a capital-efficient post-transaction strategy to advance a diversified portfolio of next-generation CAR-T ...

Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...

Signalling a growing strategic shift towards specialised care that integrates medical innovation with smart technologies ...

Camurus AB (CAMRF) reports robust revenue growth and strategic advancements, despite facing market challenges and investment demands.

Royalty Pharma delivered robust FY25 results, with double-digit growth in Royalty Receipts and Portfolio Receipts. Check out why RPRX stock is a buy.

Eli Lilly reinforced its push into next-generation immunology and oncology innovation through two major transactions: the planned acquisition of Orna Therapeutics and a new large-scale strategic ...

Mevion Medical Systems today announced that UNC Health, a leading academic health system based in North Carolina, has selected the MEVION S250-FIT (TM) Proton Therapy System, reinforcing the growing ...

Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and manufacturing organization (CDMO) site in Hanover, Maryland that will ...

Through this agreement, MicrobiotiX aims to expand its clinical research footprint beyond Asia into regions with significant ...